Client NewsRoquefort Therapeutics plc: Board Appointment
Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, is pleased to announce the appointment of Ms Jean Duvall as a Non-Executive Director, and the resignation of Mr Mark Rollins as Non-Executive Director.
OPEN AN ACCOUNT
If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.
Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.